Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia

The K562 cell line derived from a CML patient in blast crisis was examined for properties of B and T lymphocytes and cell lines. K562 lacks the B markers of immunoglobulin, Epstein‐Barr virus (EBV) genome and associated nuclear antigen, and receptors for EBV. A low proportion of cells form rosettes with sheep erythrocytes, the frequency of which is considerably increased after neuraminidase treatment. Unlike B lines but like T lines, K562 cells are lysed rapidly by C'/Fc receptor‐positive human blood leukocytes and do not stimulate MLC reactions. On the other hand, K562 lacks T antigen, high radiosensitivity and sensitivity to growth inhibition by thymidine. The cells do not contain N‐APase, an enzyme found in all lines derived from lymphoid cells and in lymphoproliferative diseases. By scanning electron microscopy, K562 cells were seen to be rounded and relatively smooth, with small numbers of short microvilli resembling undifferentiated leukemic cells. A few cells had narrow ridge‐like profiles and small ruffles similar to granulocytic leukemic cells. K562 is strongly positive for immunoglobulin Fc receptors and pinocytosis, but does not phagocytose or mediate antibody‐dependent phagocytosis or cytolysis. Among histochemical stains, K562 is positive for esterase, lipid, and acid phosphatase. There seems to be no doubt that K562 is not a B cell line. While it has some T cell properties, these are not exclusive. Some of its characteristics indicate that it is probably not lymphoid. Due to its low level of differentiation, its nature cannot be stated with certainty. On the basis of the possible presence of the cellular marker of chronic myeloid leukemia, the Ph chromosome, it may be regarded as belonging to the granulocytic series of cells.

[1]  G. Klein,et al.  SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES , 1973, The Journal of experimental medicine.

[2]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[3]  J. Minowada,et al.  In vitro preferential effect of irradiation on cultured T lymphoid cell line. , 1974, Clinical and experimental immunology.

[4]  C. Lozzio,et al.  Cytotoxicity of a factor isolated from human spleen. , 1973, Journal of the National Cancer Institute.

[5]  G. Klein,et al.  Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. , 1974, Intervirology.

[6]  E. Klein,et al.  Comparative study of alkaline phosphatase activity in lymphocytes, mitogen-induced blasts, lymphoblastoid cell lines, acute myeloid leukemia, and chronic lymphatic leukemia cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Catovsky T-CELL ORIGIN OF ACID-PHOSPHATASE-POSITIVE LYMPHOBLASTS , 1972, The Lancet.

[8]  H. Pross,et al.  Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations , 1975, International journal of cancer.

[9]  J. Pontén,et al.  Classification and biological nature of established human hematopoietic cell lines , 1975, International journal of cancer.

[10]  D. Baltimore,et al.  Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes. , 1975, The New England journal of medicine.

[11]  V. Diehl,et al.  Demonstration of a Herpes Group Virus in Cultures of Peripheral Leukocytes from Patients with Infectious Mononucleosis , 1968, Journal of virology.

[12]  B. Andersson,et al.  Evidence for a Receptor Recognizing Antigen Complexed Immunoglobulin on the Surface of Activated Mouse Thymus Lymphocytes , 1972, Scandinavian journal of immunology.

[13]  N. Goldblum,et al.  Concanavalin A receptors on the surface membrane of lymphocytes from patient's with Hodgkin's disease and other malignant lymphomas. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Epstein,et al.  Biology of the human malignant lymphomas I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas , 1974, Cancer.

[15]  K. Nilsson,et al.  Establishment and characteristics of two unique cell lines from patients with lymphosarcoma , 1974, International journal of cancer.

[16]  F. Deinhardt,et al.  Herpesvirus ateles: Transformation in vitro of marmoset splenic lymphocytes , 1974, International journal of cancer.

[17]  P. Ralph,et al.  Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line , 1975, Nature.

[18]  K. Wilson,et al.  A comparative biochemical study of alkaline phosphatases in normal and leukemic mice. , 1971, Cancer research.

[19]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.

[20]  G. Klein,et al.  Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.

[21]  G. Klein,et al.  Sensitivity of Epstein‐Barr virus (EBV) producer and non‐producer human lymphoblastoid cell lines to superinfection with EB‐virus , 1972, International journal of cancer.

[22]  K. Nilsson,et al.  Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.

[23]  K. Nilsson,et al.  β2-Microglobulin Production in Vitro by Human Hematopoietic, Mesenchymal, and Epithelial Cells , 1974, The Journal of Immunology.

[24]  B. Clarkson,et al.  A scanning electron microscopic study of 34 cases of acute granulocytic, myelomonocytic, monoblastic and histiocytic leukemia. , 1975, The American journal of medicine.

[25]  G. Moore,et al.  Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines. , 1975, Journal of the National Cancer Institute.

[26]  G. Klein Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease. , 1975, Cold Spring Harbor symposia on quantitative biology.

[27]  R. Herberman,et al.  A human lymphoid cell line with receptors for both sheep red blood cells and complement. , 1974, Cellular immunology.

[28]  C. Lozzio,et al.  Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells , 1976, The Journal of experimental medicine.

[29]  B. Giovanella,et al.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. , 1975, Intervirology.

[30]  G. Moore,et al.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. , 1972, Journal of the National Cancer Institute.

[31]  R. Russell,et al.  Distinct Alkaline Phosphatase in Serum of Patients with Lymphatic Leukemia and Infectious Mononucleosis , 1974, Science.

[32]  G. Klein,et al.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[33]  George,et al.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. , 1968, Cancer research.

[34]  J. Stjernswärd,et al.  Cellular immunity against tumor‐associated antigens in humans: Lymphocyte stimulation and skin reaction , 1974, International journal of cancer.

[35]  R. Pulvertaft A study of malignant tumours in Nigeria by short-term tissue culture , 1965, Journal of clinical pathology.

[36]  H. Lazarus,et al.  Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia , 1965, Cancer.

[37]  E. Klein,et al.  An established Burkitt's lymphoma line with cell membrane IgG. , 1975, Clinical immunology and immunopathology.

[38]  H. Wigzell,et al.  SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES , 1972, The Journal of experimental medicine.

[39]  G. Klein,et al.  Some factors affecting membrane immunofluorescence reactivity of burkitt lymphoma tissue culture cell lines , 1969, International journal of cancer.